Not available
Quote | Achieve Life Sciences Inc. (NASDAQ:ACHV)
Last: | $4.85 |
---|---|
Change Percent: | -0.61% |
Open: | $4.98 |
Close: | $4.85 |
High: | $4.99 |
Low: | $4.78 |
Volume: | 152,859 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
News | Achieve Life Sciences Inc. (NASDAQ:ACHV)
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that...
Message Board Posts | Achieve Life Sciences Inc. (NASDAQ:ACHV)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ACHV News Article - Achieve Life Sciences Inc. (NASDAQ: ACHV) Climbs to New 52-Week Hi | whytestocks | investorshangout | 04/26/2023 6:35:47 PM |
whytestocks: $ACHV News Article - Achieve Life Sciences to Announce First Quarter 2023 Financial Res | whytestocks | investorshangout | 04/26/2023 4:00:50 PM |
whytestocks: $ACHV News Article - Achieve Life Sciences Announces Refresh to Board of Directors | whytestocks | investorshangout | 03/30/2023 2:10:53 PM |
whytestocks: $ACHV News Article - Achieve Life Sciences Announces Last Subject Last Visit Completed | whytestocks | investorshangout | 03/08/2023 1:25:47 PM |
whytestocks: $ACHV News Article - Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 | whytestocks | investorshangout | 03/03/2023 7:25:53 PM |
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that...
SEATTLE and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced that the c...